2seventy bio Statistics
Total Valuation
CRK has a market cap or net worth of $4.62 billion. The enterprise value is $7.69 billion.
Important Dates
The last earnings date was Wednesday, July 30, 2025, after market close.
| Earnings Date | Jul 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CRK has 293.07 million shares outstanding. The number of shares has increased by 3.54% in one year.
| Current Share Class | 293.07M |
| Shares Outstanding | 293.07M |
| Shares Change (YoY) | +3.54% |
| Shares Change (QoQ) | +1.36% |
| Owned by Insiders (%) | 2.22% |
| Owned by Institutions (%) | 30.43% |
| Float | 86.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 15.90 |
| PS Ratio | 2.80 |
| Forward PS | 2.23 |
| PB Ratio | 2.08 |
| P/TBV Ratio | 2.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 5.19 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.65 |
| EV / EBITDA | 8.65 |
| EV / EBIT | 50.48 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.36, with a Debt / Equity ratio of 1.28.
| Current Ratio | 0.36 |
| Quick Ratio | 0.28 |
| Debt / Equity | 1.28 |
| Debt / EBITDA | 3.48 |
| Debt / FCF | n/a |
| Interest Coverage | 0.70 |
Financial Efficiency
Return on equity (ROE) is -2.74% and return on invested capital (ROIC) is 1.75%.
| Return on Equity (ROE) | -2.74% |
| Return on Assets (ROA) | 1.46% |
| Return on Invested Capital (ROIC) | 1.75% |
| Return on Capital Employed (ROCE) | 2.56% |
| Revenue Per Employee | $6.46M |
| Profits Per Employee | -$283,434 |
| Employee Count | 256 |
| Asset Turnover | 0.25 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -96.47M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +61.64% in the last 52 weeks. The beta is 0.28, so CRK's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | +61.64% |
| 50-Day Moving Average | 23.17 |
| 200-Day Moving Average | 19.38 |
| Relative Strength Index (RSI) | 21.47 |
| Average Volume (20 Days) | 2,590,331 |
Short Selling Information
The latest short interest is 17.55 million, so 5.99% of the outstanding shares have been sold short.
| Short Interest | 17.55M |
| Short Previous Month | 20.45M |
| Short % of Shares Out | 5.99% |
| Short % of Float | 20.27% |
| Short Ratio (days to cover) | 5.93 |
Income Statement
In the last 12 months, CRK had revenue of $1.65 billion and -$72.56 million in losses. Loss per share was -$0.25.
| Revenue | 1.65B |
| Gross Profit | 936.86M |
| Operating Income | 152.34M |
| Pretax Income | -64.88M |
| Net Income | -72.56M |
| EBITDA | 889.08M |
| EBIT | 152.34M |
| Loss Per Share | -$0.25 |
Full Income StatementBalance Sheet
The company has $25.86 million in cash and $3.11 billion in debt, giving a net cash position of -$3.08 billion or -$10.51 per share.
| Cash & Cash Equivalents | 25.86M |
| Total Debt | 3.11B |
| Net Cash | -3.08B |
| Net Cash Per Share | -$10.51 |
| Equity (Book Value) | 2.43B |
| Book Value Per Share | 7.66 |
| Working Capital | -479.17M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $887.53 million and capital expenditures -$1.15 billion, giving a free cash flow of -$264.06 million.
| Operating Cash Flow | 887.53M |
| Capital Expenditures | -1.15B |
| Free Cash Flow | -264.06M |
| FCF Per Share | -$0.90 |
Full Cash Flow StatementMargins
Gross margin is 56.61%, with operating and profit margins of 9.20% and -4.38%.
| Gross Margin | 56.61% |
| Operating Margin | 9.20% |
| Pretax Margin | -9.80% |
| Profit Margin | -4.38% |
| EBITDA Margin | 53.72% |
| EBIT Margin | 9.20% |
| FCF Margin | n/a |
Dividends & Yields
CRK does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.54% |
| Shareholder Yield | -3.54% |
| Earnings Yield | -1.57% |
| FCF Yield | -5.73% |
Dividend DetailsAnalyst Forecast
The average price target for CRK is $21.00, which is 33.25% higher than the current price. The consensus rating is "Hold".
| Price Target | $21.00 |
| Price Target Difference | 33.25% |
| Analyst Consensus | Hold |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CRK has an Altman Z-Score of 1.07 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.07 |
| Piotroski F-Score | 5 |
